Sweden-based Elekta has signed a $29m agreement to deliver several of its Versa HD linear accelerators as well as software support and services to The Ottawa Hospital (TOH) in Ontario, Canada.
The agreement is for a period of more than eight years. Elekta has scheduled the initial Versa HD deliveries for this year.
Go deeper with GlobalData
The Ottawa Hospital Radiation Oncology head Dr Jason Pantarotto said: “Elekta’s Versa HD linear accelerators will enable us to treat a broad spectrum of tumours throughout the body.
“The advanced technology will help us increase the use of high dose radiation treatments such as stereotactic body radiotherapy. These treatments reduce the total number of patient visits while improving clinical effectiveness.”
Claimed to be the high-versatility treatment system, Versa HD gives clinicians the flexibility to deliver conventional therapies to treat several small as well as large tumours throughout the body.
Highly complex cancers that require extreme targeting precision can also be treated using the system.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataElekta North America executive vice-president Pete Gaccione said: “We share The Ottawa Hospital’s vision to provide each patient with the world-class care. This agreement will provide thousands of patients at the hospital the opportunity to receive advanced cancer care.”
Every year, more than 85,000 people are diagnosed with cancer in Ontario.
